WHO Committee Wants Global Rules On Gene-Editing Patents

By Dani Kass (July 14, 2021, 4:04 PM EDT) -- A World Health Organization committee is encouraging those who hold patents for genome editing tools to make sure access to the technology is equitably spread across the globe and is recommending the creation of ethical guidelines.

An advisory committee on developing global standards for governance and oversight of human genome editing suggested on Monday that the WHO should pull together representatives from patent owners and applicants, industry groups, the World Intellectual Property Organization and the World Trade Organization to figure out ethical licensing requirements for related patents.

Anything less than a worldwide effort could lead to some countries having heavy regulations...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!